These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 3697988

  • 1. Antigens expressed on NIH 3T3 cells following transformation with DNA from human pancreatic tumor.
    Hollingsworth MA, Rebellato LM, Moore JW, Finn OJ, Metzgar RS.
    Cancer Res; 1986 May; 46(5):2482-7. PubMed ID: 3697988
    [Abstract] [Full Text] [Related]

  • 2. A novel ribonucleoprotein complex defined by monoclonal antibodies to NIH 3T3 cells transfected with human pancreatic adenocarcinoma DNA.
    Hollingsworth MA, Borowitz MJ, Everett ML, Metzgar RS.
    Cancer Res; 1990 Sep 15; 50(18):6015-22. PubMed ID: 2393865
    [Abstract] [Full Text] [Related]

  • 3. Tumor rejection antigens on BALB3T3 cells transformed by activated oncogenes.
    Torigoe T, Sato N, Takashima T, Cho JM, Tsuboi N, Qi WM, Hara I, Wada Y, Takahashi N, Kikuchi K.
    J Immunol; 1991 Nov 01; 147(9):3251-8. PubMed ID: 1919013
    [Abstract] [Full Text] [Related]

  • 4. A novel approach to production of antitumor monoclonal antibodies: antibody to a cell surface glycoprotein associated with transformation by a human oncogene.
    Roth JA, Scuderi P, Westin E, Gallo RC.
    Surgery; 1984 Aug 01; 96(2):264-72. PubMed ID: 6379959
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Transfer of a dominant-acting tumor-inducing oncogene from human prostatic carcinoma cells to cloned rat embryo fibroblast cells by DNA-transfection.
    Su ZZ, Olsson CA, Zimmer SG, Fisher PB.
    Anticancer Res; 1992 Aug 01; 12(2):297-304. PubMed ID: 1580547
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Aberrations in interleukin-1 expression in oncogene-transformed fibrosarcoma lines: constitutive interleukin-1 alpha transcription and manifestation of biological activity.
    Douvdevani A, Huleihel M, Segal S, Apte RN.
    Eur Cytokine Netw; 1991 Aug 01; 2(4):257-64. PubMed ID: 1756231
    [Abstract] [Full Text] [Related]

  • 10. Regulation of epidermal growth factor receptor by activated H-ras and V-myc oncogenes in mouse Balb/3T3 cells: possible roles of AP-1.
    Okimoto T, Kohno K, Kuwano M, Gopas J, Kung HF, Ono M.
    Oncogene; 1996 Apr 18; 12(8):1625-33. PubMed ID: 8622882
    [Abstract] [Full Text] [Related]

  • 11. A mutant cell line derived from NIH/3T3 cells: two oncogenes required for in vitro transformation.
    Katz E, Carter BJ.
    J Natl Cancer Inst; 1986 Oct 18; 77(4):909-14. PubMed ID: 3463820
    [Abstract] [Full Text] [Related]

  • 12. Specific expression of cellular oncogenes c-myc and c-myb in T-cell lines established from three types of bovine lymphosarcomas.
    Ishiguro N, Matsui T, Shinagawa M.
    Am J Vet Res; 1993 Dec 18; 54(12):2010-4. PubMed ID: 8116930
    [Abstract] [Full Text] [Related]

  • 13. [Analysis of c-onc genes in choriocarcinoma cells].
    Fujino T.
    Hokkaido Igaku Zasshi; 1987 Sep 18; 62(5):798-807. PubMed ID: 3692432
    [Abstract] [Full Text] [Related]

  • 14. Tumorigenesis by transected cells in nude mice: a new method for detecting cellular transforming genes.
    Blair DG, Cooper CS, Oskarsson MK, Eader LA, Vande Woude GF.
    Prog Clin Biol Res; 1983 Sep 18; 119():79-90. PubMed ID: 6346333
    [Abstract] [Full Text] [Related]

  • 15. Invasiveness and chemotactic activity of oncogene transformed NIH/3T3 cells.
    Melchiori A, Carlone S, Allavena G, Aresu O, Parodi S, Aaronson SA, Albini A.
    Anticancer Res; 1990 Sep 18; 10(1):37-44. PubMed ID: 2334141
    [Abstract] [Full Text] [Related]

  • 16. Activation of c-Ki-ras gene in human pancreatic cancer.
    Prassolov VS, Sakamoto H, Nishimura S, Terada M, Sugimura T.
    Jpn J Cancer Res; 1985 Sep 18; 76(9):792-5. PubMed ID: 3932275
    [Abstract] [Full Text] [Related]

  • 17. Raf revertant cells resist transformation by non-nuclear oncogenes and are deficient in the induction of early response genes by TPA and serum.
    Kolch W, Heidecker G, Troppmair J, Yanagihara K, Bassin RH, Rapp UR.
    Oncogene; 1993 Feb 18; 8(2):361-70. PubMed ID: 8426742
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Detection and preliminary characteristics of the transforming gene (oncogene) of Ha-ras type in human stomach cancer].
    Kniazev PG, Schäfer R, Kalinovskiĭ VP, Matveev BV, Mel'nikov RA.
    Mol Biol (Mosk); 1986 Feb 18; 20(6):1513-21. PubMed ID: 3027534
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.